Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-20T03:50:47.775Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum caeruloplasmin as a coronary risk factor in the elderly: the Rotterdam Study

Published online by Cambridge University Press:  09 March 2007

Kerstin Klipstein-Grobusch ,
Diederick E. Grobbee ,
J. F. Koster ,
J. Lindemans ,
Heiner Boeing ,
Albert Hofman  and
Jacqueline C. M. Witteman
Kerstin Klipstein-Grobusch
Affiliation:
Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany
Diederick E. Grobbee
Affiliation:
Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands Julius Center for Patient Oriented Research, Utrecht University Hospital, The Netherlands
J. F. Koster
Affiliation:
Department of Biochemistry, Cardiovascular Research Institute, Erasmus University, Rotterdam, The Netherlands
J. Lindemans
Affiliation:
Central Clinical Chemical Laboratory, Erasmus University, Rotterdam, The Netherlands
Heiner Boeing
Affiliation:
Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands
Albert Hofman
Affiliation:
Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands
Jacqueline C. M. Witteman*
Affiliation:
Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands
*
*Corresponding author: Dr Jacqueline C. M. Witteman, fax +31 10 436 5933, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Serum Cu and caeruloplasmin levels have been suggested to be independent risk factors for CHD operating through oxidative modification of LDL. However, given its function as an acute-phase protein, the question has been raised whether an elevated caeruloplasmin level is not merely an indicator of inflammation. In the current study, we investigated whether serum caeruloplasmin was associated with subsequent myocardial infarction, taking into account indices of inflammation. The study population consisted of 210 cases of first myocardial infarction and controls, frequency-matched on age (5-year categories) and sex, selected from the population-based cohort of the Rotterdam Study. Serum caeruloplasmin levels were significantly elevated in cases of myocardial infarction compared with controls (510 (sd 110) v. 470 (sd 100) mg/1; P = 0·007). Risk of myocardial infarction for the highest compared with the lowest quartile of caeruloplasmin was 2·46 (95 % CI 1·04, 6·00; Ptrend = 0·043) after adjustment for age, sex, BMI, pack-years smoked, serum cholesterol, systolic blood pressure, and income. The relative risk was most evident in current smokers. Adjustment for C-reactive protein and leucocyte count reduced the excess risk by 33 %. This suggests that a substantial part of the observed association between serum caeruloplasmin and CHD may be attributed to inflammation processes rather than to the pro-oxidant activity of caeruloplasmin.

Keywords

Serum caeruloplasminMyocardial infarctionInflammation
Type
Research Article
Information
British Journal of Nutrition , Volume 81 , Issue 2 , February 1999 , pp. 139 - 144
Copyright
Copyright © The Nutrition Society 1999

References

Craig, WY, Poulin, SE, Palomaki, GE, Neveux, LM, Ritchie, RF & Ledue, TB (1995) Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects. Arteriosclerosis Thrombosis and Vascular Biology 15, 733–739.CrossRefGoogle ScholarPubMed
Ehrenwald, E, Chisolm, GM & Fox, PL (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. Journal of Clinical Investigation 93, 1493–1501.CrossRefGoogle ScholarPubMed
Ernst, E & Resch, KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Annals of Internal Medicine 118, 956–963.CrossRefGoogle ScholarPubMed
Fox, PL, Mukhopadhyay, C & Ehrenwald, E (1995) Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sciences 56, 1749–1758.CrossRefGoogle ScholarPubMed
Haverkate, F, Thompson, SG, Pyke, SDM, Gallimore, JR & Pepys, MB for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349, 462–466.CrossRefGoogle ScholarPubMed
Hofman, A, Grobbee, DE, De Jong, PTVM & Vandenouweland, FA (1991) Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. European Journal of Epidemiology 7, 403–422.CrossRefGoogle ScholarPubMed
Klipstein-Grobusch, K, den Breeijen, JH, Goldbohm, RA, Geleijnse, JM, Hofman, A, Grobbee, DE & Witteman, JCM (1998) Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. European Journal of Clinical Nutrition 52, 588–596.CrossRefGoogle ScholarPubMed
Kok, FJ, van Duijn, CM, Hofman, A, van der Voet, GB, de Wolff, FA, Paays, CHCH & Valkenburg, HA (1988) Serum copper and zinc and the risk of death from cancer and cardiovascular disease. American Journal of Epidemiology 128, 352–359.CrossRefGoogle ScholarPubMed
Kuller, LH, Tracy, RP, Shaten, J & Meilahn, EN, for the MRFIT Research Group (1996) Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. American Journal of Epidemiology 144, 537–547.Google ScholarPubMed
Lamb, DJ & Leake, DS (1994) Acidic pH enables ceruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Letters 338, 122–126.CrossRefGoogle ScholarPubMed
Mänttäri, M, Manninen, V, Huttunen, JK, Palosuo, T, Ehnholm, C, Heinonen, OP & Frick, MH (1994) Serum ferritin and ceruloplasmin as coronary risk factors. European Heart Journal 15, 1599–1603.CrossRefGoogle ScholarPubMed
Reunanen, A, Knekt, P & Aaran, R-K (1992) Serum ceruloplasmin level and the risk of myocardial infarction and stroke. American Journal of Epidemiology 136, 1082–1090.CrossRefGoogle ScholarPubMed
Reunanen, A, Knekt, P, Marniemi, J, Mäki, J, Maatela, J & Aromaa, A (1996) Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. European Journal of Clinical Nutrition 50, 431–437.Google ScholarPubMed
Rosengren, A & Wilhelmsen, L (1996) Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933. Journal of Internal Medicine 239, 499–507.CrossRefGoogle Scholar
Salonen, JT, Salonen, R, Korpela, H, Suntioiun, S & Tuomilehto, J (1991 a) Serum copper and the risk of acute myocardial infarction: a prospective study in men in Eastern Finland. American Journal of Epidemiology 134, 268–276.CrossRefGoogle ScholarPubMed
Salonen, JT, Salonen, R, Seppänen, K, Kantola, M, Suntioinen, S & Korpela, H (1991 b) Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. British Medical Journal 302, 756–760.CrossRefGoogle ScholarPubMed
World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems, vol. 1, 10th revision. Geneva: WHO.Google Scholar
Yarnell, JW, Baker, IA, Sweetnam, PM, Bainton, D, O'Brien, JR, Whitehead, PJ & Elwood, PC (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83, 836–844.CrossRefGoogle ScholarPubMed